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male runners completed a one-mile race 60 minutes following the ingestion of 0.09 g·kg - 
Introduction
Caffeine, often in the form of coffee 1 , is frequently supplemented by athletes in an attempt to facilitate improved performance during exercise. However, the available research typically focuses on the ingestion of 3-8 mg·kg -1 of anhydrous caffeine rather than coffee 1 . Caffeine non-selectively blocks both adenosine receptors and competitively inhibits the action of adenosine, which during exercise, can lower pain perception, increase neuro-excitability and sustain motor unit firing 2 .
Therefore, adenosine receptor antagonism is the leading hypothesis as to how caffeine could have an ergogenic effect on exercise performance 2 . Despite this, Astorino and Roberson 3 concluded that the mechanism by which caffeine provides an ergogenic effect in high intensity exercise is likely to be multifactorial, with central factors such as adenosine antagonism being the most probable mechanism, but with reductions in perceived exertion, and increased reaction time, cognition, and mood also having an influence on performance.
Recently, there has been debate as to whether the same ergogenic benefits observed from caffeine ingestion can be obtained from consuming caffeine in the form of coffee, especially as Liguori et al. 4 reported that peak salivary caffeine concentration was faster and higher following coffee ingestion, compared with a caffeine capsule. However, Graham et al. 5 8, 14 , it would be beneficial to investigate the effect of coffee ingestion on actual race performance, as no previous study has investigated the effect of coffee ingestion on performance in ecologically valid situations such as a competitive race. Therefore, the aim of the present study was to provide an insight into the effectiveness of coffee ingestion as an ergogenic aid prior to a one-mile (1609 m) race in trained males.
Methods

Participants
Fifteen trained middle distance male runners began the study, although only 13 (Mean ± SD age: performance variation due to circadian variation 15 . Participants were instructed to abstain from caffeine, alcohol, and strenuous activity for 12 h prior to each race. Caffeine was not withheld for the 24-h period prior because it has been demonstrated that a 3 mg·kg −1 body mass dose of caffeine improves performance irrespective of whether a withdrawal period is imposed on habitual caffeine users 16 . In addition, the participants had not been taking any additional supplements, such as beta alanine, that may influence running performance for at least three months prior to data collection.
Trials were separated by a period of seven days to ensure complete recovery. Habitual caffeine consumption was assessed using an adapted version of the Landrum et al. 17 caffeine consumption questionnaire. Many participants were regular consumers of caffeine (mean ± SD: 171 ± 250 mg·day -1 and range: 0-705 mg·day -1 ) with low habitual caffeine consumption defined as <300 mg·day -1 and >300 mg·day -1 was defined as high 18 . In addition, a 24-hour dietary record was completed by each participant prior to the first race; it was then photocopied and handed back to the participants so that the same diet could be repeated for subsequent trials (Daily energy: 2738 ± 650 Kcal; Carbohydrate: 394 ± 95 g; Protein: 95 ± 32 g; Fat: 98 ± 29 g; Water: 2409 ± 2132 ml).
Coffee Treatments
Each participant competed in three races following the ingestion of the following: 0.09 g·kg -1 coffee (Nescafé Original, Nestlé, UK; COF), 0.09 g·kg -1 decaffeinated coffee (Nescafé Original Decaffeinated, Nestlé, UK; DEC), and a placebo (PLA). Nescafé original coffee (from the same batch) was used in the coffee trials as it has been reported by Hodgson et al. 6 to contain 3.4 g of caffeine per 100 g of coffee meaning that each participant consumed 0.09 g·kg -1 of coffee to achieve the 3 mg·kg -1 of caffeine required. Nescafé decaffeinated coffee was used and provides ~0.17 mg·kg -1 of caffeine 6 and was prepared in identical fashion and concentration to the coffee trial. All trials were dissolved in 300 ml of hot water (65.8 ± 3.1ºC) and served in lidded cups. The were removed. The one mile was timed using electronic timing lights (ALGE Timing GmbH, Lustenau, Austria). Time to completion was not given to the participants until after the end of the study. To ensure maximum effort, the races were handicapped based on the participants' personal best time and adjusted based on their performance for the following race to ensure each trial was a competitive race e.g. a participant with a one-mile personal best of 04:22 mm:ss started 3 s after a participant with a personal best of 04:25 mm:ss. Furthermore, the participants received £2 for each place in every race i.e. £2 for 13 th and £26 for 1 st and an additional £50 gift voucher for the overall winner based on accumulated prize money.
Measurements
Heart rate (HR) was measured throughout each race using a short-range telemetry HR transmitter strap recording at 1 s intervals (Polar Team 2 System, Polar Electro Oy, Kempele, Finland). Saliva samples (minimum 0.5 ml by the passive drool technique) were obtained immediately before fluid ingestion to establish compliance with the washout period, one-hour post-ingestion and following the race. Participants were instructed to expectorate into a 20-ml plastic cup, and the sample was then transferred to a capped glass vial that was immediately placed in a portable −20°C freezer before being transferred to a −80°C freezer for subsequent analysis of caffeine concentration using a standard enzyme-linked immunoassay kit (Caffeine ELISA Kit; Creative Diagnostics, Shirley, USA). At the same time points, a capillary blood sample was drawn from the index finger for determination of blood glucose and lactate concentrations (Biosen C-line, EKF-diagnostic GmbH, Germany).
Data Analysis
An a priori power calculation based for race time revealed that a sample size of ten participants were necessary to detect a statistical difference given an estimated effect size of 0.5, a 1-β error probability of 0.8 and a P value of less than 0.05. Data are reported as the mean ± the standard deviation (SD). The Shapiro-Wilk test was applied to the data to assess for a normal distribution.
All variables, except for salivary caffeine and blood glucose and lactate were assessed using a oneway analysis of variance (ANOVA) with repeated measures. Salivary caffeine concentration and blood glucose and lactate were analysed with a two-way ANOVA with repeated measures. were also calculated. In addition, the changes in race performance were standardized and expressed as a factor of the smallest worthwhile change, based on Cohen's effect size principle.
Results
The results show a large main effect for trial (F2,24=9.524; P=0.001; 2 P  =0.44; Figure 1) 
Discussion
The aim of the present study was to determine the effect of ingesting caffeinated coffee on onemile (1609 m) race performance. The main findings are that the ingestion of COF markedly increased salivary caffeine concentration and improved one-mile race performance compared with DEC and PLA. In addition, blood glucose and lactate concentration, and maximal heart rate were unaffected by the ingestion of COF or DEC.
Following the ingestion of caffeinated coffee race performance was improved by 1.9% and 1.3% compared with PLA and DEC respectively. The ergogenic benefits of caffeine ingestion are well documented (e.g. 3, 21 7 reported that caffeine and coffee ingestion improved total work performed during repeated sprints (95%CI: 40, 219 J). In contrast, Clarke et al. 20 observed that the ingestion of coffee had little effect on repeated sprint cycling performance in relatively untrained males. Graham et al. 5 previously suggested that the bioactive compounds in coffee, such as chlorogenic acids, may attenuate the ergogenic effect of caffeine. However, more recent studies 6, 7, 14 have reported both coffee and caffeine ingestion yield similar benefits for exercise performance, most likely through the antagonistic effect on adenosine receptors reducing symptoms of central fatigue 1 . One potential reason for the inconsistent findings is training status. It is apparent that caffeine and coffee is less effective for non-trained individuals participating in high-intensity exercise 12 , possibly due to trained athletes, like the participants in the present study, having more muscle mass than recreational athletes and the concentration of adenosine receptors (the hypothesised primary target of caffeine 2 ) appearing to be higher in trained compared to untrained individuals 21 . In addition, the high variability in performance that is typical for untrained subjects may also contribute.
Although the purpose of this study was not to determine the mechanism of coffee action, adenosine antagonism, enhanced motor unit recruitment and reduced perception of pain and exertion have been proposed to explain the effects of caffeine supplementation on sport performance 2 . However, since caffeine interacts with many tissues, it is difficult to independently investigate its effects on the central and peripheral nervous systems, and metabolism 22 . When specifically examining exercise of the nature in the present study, the primary mechanisms by which caffeine exerts its ergogenic effects are considered to arise from the antagonism of adenosine receptors leading to an increase in neurotransmitter release and motor unit firing rates, pain suppression, reduced fatigue and improved neuromuscular performance 2 . Another possible mechanism through which caffeine may improve performance is by increasing the secretion of β-endorphins 23 , which may, at least partially, explain the mechanism by which caffeine attenuates pain sensation 24 and rating of perceived exertion 25 during exercise, thereby decreasing perceptions of effort and improving performance, as observed in the present study.
In addition to its impact on the central nervous system, caffeine can affect substrate utilization during exercise with a decrease in glycogen utilization and an increase in free fatty acid mobilization 26 . However, alterations in substrate utilization is unlikely to mediate performance changes in the present study due to fat metabolism representing a minor substrate and muscle glycogen not being limiting 2 . In addition, de Paulis, et al. 27 demonstrated that coffee ingestion caused a blunted response of adrenaline which was attributed to chlorogenic acids antagonising the binding of caffeine to adenosine receptors. Furthermore, Hodgson, et al. 6 reported that the increase in glucose, fatty acids and glycerol observed when ingesting caffeine had an attenuated response following coffee ingestion, which was attributed to other compounds in coffee inducing subtle effects on the antagonism of A1 and A2A adenosine receptors. Despite these findings, the performance improvements observed by Hodgson, et al. 6 were similar for both caffeine and coffee leading the authors to conclude coffee ingestion may alter the metabolic effects, but not the ergogenic effects on performance. In support of this observation, McLellan and Bell 14 and Trexler et al. 7 reported similar performance benefits from ingesting coffee and caffeine. However, in the present study no differences in blood glucose and lactate concentrations, and heart rate were observed, although these values were comparable with previous studies 5, 8, 14 . Overall, it is probable that coffee and caffeine supplementation enhances physical performance via a combined effect on both the central and peripheral systems.
The present study is not without limitations. The use of a 24-hour dietary record to ensure pre-trial standardisation, whilst being an acceptable method and a good reflection of standard nutritional practice, there may be some concern about the accuracy. In addition, the baseline salivary caffeine concentrations suggest that caffeine was not abstained from prior to each trial. However, both factors are likely to provide a more ecologically valid condition and represent typical pre-race preparation. A further potential limitation is the wide range of the participants' habitual caffeine intake, although Gonçalves et al. 28 recently demonstrated that during ~30 min cycling time trials, performance was not influenced by habitual caffeine consumption.
Practical Implications
The coefficient of variation (CV) for running performance at distances between 1500 m and 10,000 m for elite males has been reported to be 1.4% (90%CI: 1.2-1.6) 29 and the smallest worthwhile enhancement in performance of similar distances to be 0.3-0.5 of the CV 29 . In the present study, based on the placebo condition, this corresponds to a 1. 
Conclusion
In conclusion, the ingestion of caffeinated coffee 60 minutes before a one-mile race markedly increased salivary caffeine concentration and improved race performance compared with decaffeinated coffee and a placebo solution. These findings suggest that the ingestion of caffeinated coffee is a suitable source of caffeine prior to a one-mile running race. * COF higher than PLA (d=2.34) and DEC (d=2.47).
# COF higher than PLA (d=1.99) and DEC (d=1.83). # * Table 1 : Blood glucose and lactate at baseline, post-warm-up and post-race, and heart rate postwarm-up and maximum value achieved during each race.
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